41. Antipsychotics prescribed for one in three children at clinical high risk for psychosis. Issue 4 (11th March 2022) Authors: Knopf, Alison Journal: Brown University child & adolescent psychopharmacology update Issue: Volume 24:Issue 4(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. Anxiety more likely in children with chronic medical conditions. Issue 2 (15th January 2020) Authors: Knopf, Alison Journal: Brown University child & adolescent psychopharmacology update Issue: Volume 22:Issue 2(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. APA meeting features SUD issues. Issue 8 (12th July 2022) Authors: Knopf, Alison Journal: Brown University child & adolescent psychopharmacology update Issue: Volume 24:Issue 8(2022) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. App helps patients through yearlong post‐treatment recovery. Issue 4 (22nd March 2019) Journal: Brown University child & adolescent psychopharmacology update Issue: Volume 21:Issue 4(2019) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. Appriss Health integrates EHR and PDMP data; information flows one way. Issue 9 (21st August 2019) Journal: Brown University child & adolescent psychopharmacology update Issue: Volume 21:Issue 9(2019) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. Approach to drug crisis shifts as illicit fentanyl and heroin overtake prescription opioids. Issue 12 (28th November 2017) Journal: Brown University child & adolescent psychopharmacology update Issue: Volume 19:Issue 12(2017) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. Aripiprazole associated with adverse effects in pediatric population. Issue 10 (October 2016) Journal: Brown University child & adolescent psychopharmacology update Issue: Volume 18:Issue 10(2016:Oct.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. Aripiprazole found safe, tolerable, and effective in placebo‐controlled maintenance study. Issue 9 (September 2017) Journal: Brown University child & adolescent psychopharmacology update Issue: Volume 19:Issue 9(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. Aripiprazole versus quetiapine: Response/non‐response can be predicted at 2–4 weeks. Issue 4 (11th March 2022) Authors: Knopf, Alison Journal: Brown University child & adolescent psychopharmacology update Issue: Volume 24:Issue 4(2022) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. Article warns against using antipsychotic medications for nonpsychotic children. Issue 3 (March 2016) Journal: Brown University child & adolescent psychopharmacology update Issue: Volume 18:Issue 3(2016:Mar.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗